Related Experiment Video
Updated: Jun 14, 2026
05:01
A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
Published on: July 1, 2020
Pathway genetic load allows simultaneous evaluation of multiple genetic associations
Ryan M Huebinger1, Harold R Garner, Robert C Barber
1Department of Surgery, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390, USA.
Summary
Pathway genetic load (PGL) analysis identified significant associations between TLR4 pathway gene interactions and sepsis risk or death in burn patients. This method offers greater power for detecting genetic associations than individual locus analysis.
Area of Science:
- Genetics
- Immunology
- Computational Biology
Background:
- Genome-wide association studies (GWAS) often fail to identify the full heritability of diseases.
- Epistatic interactions among multiple genetic loci are frequently overlooked in traditional analyses.
- The Toll-like receptor 4 (TLR4) signaling pathway is implicated in sepsis development after traumatic injury.
Purpose of the Study:
- To introduce and utilize a novel method, pathway genetic load (PGL), for evaluating epistatic interactions within single gene pathways.
- To assess the association of PGL within the TLR4 pathway with sepsis risk and mortality in burn patients.
Main Methods:
- Evaluated six loci in the TLR4 pathway for their association with sepsis and death.
- Analyzed data from 155 burn patients surviving over 48 hours post-admission.
- Utilized TaqMan assay for genotype determination and multivariate logistic regression for analysis.
Main Results:
- Pathway genetic load (PGL) was significantly associated with an increased probability of complicated sepsis (aOR=1.59) and death (aOR=1.75) after adjusting for clinical factors.
- The PGL analysis revealed a notable association with sepsis and mortality.
Conclusions:
- Pathway genetic load (PGL) analysis demonstrates greater statistical power for detecting genetic associations compared to analyzing individual loci.
- This approach can help uncover the 'missing' heritability attributed to gene-gene interactions in complex diseases.
More Related Videos
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:49Multiple Allele Traits
The Concept of Multiple Allelism
01:49Multiple Allele Traits
The Concept of Multiple Allelism
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...